Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immunometabolic remodeling of perivascular adipose tissue in murine lupus: implications for lupus vasculopathy.

bioRxiv : the preprint server for biology·2026

Same author

Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular Risk.

JCO oncology practice·2026

Same author

Variation in <i>SNX29</i> and Acute Vasodilator Response in Pulmonary Arterial Hypertension.

Circulation research·2026

Same author

Histone Deacetylase 9 Gene Deletion Ameliorates Aging-Related Adipose Tissue Senescence and Mitochondrial Dysfunction in Mice.

Aging cell·2026

Same author

Racial disparity in microvascular function among non-Hispanic white and non-Hispanic black men with newly diagnosed prostate cancer.

Physiological reports·2026

Same author

PFKFB3 activates CAD to enhance de novo pyrimidine synthesis for cell growth.

Cell reports·2026

Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026

Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026

Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026

Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026

Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026

Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 18, 2025

Enzymatic Isolation of Skeletal Muscle Interstitial Extracellular Vesicles

Enzymatic Isolation of Skeletal Muscle Interstitial Extracellular Vesicles

Published on: February 7, 2025

Extracellular Vesicles for Muscle Atrophy Treatment.

Xuan Su¹, Yan Shen¹, Il-Man Kim²

¹Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA, USA.

Advances in Experimental Medicine and Biology

|August 21, 2023

Summary

This summary is machine-generated.

Extracellular vesicles (EVs) derived from stem cells show promise in treating skeletal muscle atrophy by inhibiting the interleukin-6 (IL-6) pathway. These EVs offer anti-inflammatory and anti-fibrotic benefits for muscle regeneration.

Keywords:

Bioengineering Extracellular vesicles IL-6 Muscle atrophy Myogenic progenitor cells

More Related Videos

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

Related Experiment Videos

Last Updated: Jul 18, 2025

Enzymatic Isolation of Skeletal Muscle Interstitial Extracellular Vesicles

Enzymatic Isolation of Skeletal Muscle Interstitial Extracellular Vesicles

Published on: February 7, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

Area of Science:

Biomedical Science
Cell Biology
Regenerative Medicine

Background:

Skeletal muscle atrophy is a debilitating condition linked to aging, cancer, and muscular dystrophy.
Interleukin-6 (IL-6) is a key mediator in the progression of muscle atrophy.
Extracellular vesicles (EVs) play a role in cell-cell communication, with altered EV content potentially exacerbating muscle atrophy.

Approach:

Review of current research on stem cell-derived EVs for muscle atrophy.
Analysis of mechanisms including anti-inflammatory and anti-fibrotic effects.
Exploration of therapeutic potential of modified microRNAs (miR-26, miR-29) within EVs.

Key Points:

Muscle progenitor cell-derived EVs (MPC-EVs) may inhibit the IL-6 pathway, as suggested by RNA-Seq analysis.
EVs from stem cells, particularly those modified with specific microRNAs, can mitigate muscle atrophy.
Transplantation of MPC-EVs is a potential therapeutic strategy for muscle degenerative diseases like Duchenne muscular dystrophy (DMD).

Conclusions:

Stem cell-derived EVs present a promising avenue for treating skeletal muscle atrophy.
EVs exert therapeutic effects through anti-inflammatory and anti-fibrotic mechanisms.
Further clinical applications of EVs in muscle atrophy treatment are under investigation.